KR960701049A - 헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use) - Google Patents
헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use)Info
- Publication number
- KR960701049A KR960701049A KR1019950703745A KR19950703745A KR960701049A KR 960701049 A KR960701049 A KR 960701049A KR 1019950703745 A KR1019950703745 A KR 1019950703745A KR 19950703745 A KR19950703745 A KR 19950703745A KR 960701049 A KR960701049 A KR 960701049A
- Authority
- KR
- South Korea
- Prior art keywords
- compounds
- preparation
- heterocyclic compounds
- forebrain
- hippocampus
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000003920 cognitive function Effects 0.000 abstract 1
- 210000001320 hippocampus Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000004129 prosencephalon Anatomy 0.000 abstract 1
- 239000000021 stimulant Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/026943 | 1993-03-05 | ||
US08/026,943 US5418240A (en) | 1990-08-21 | 1993-03-05 | Heterocyclic compounds and their preparation and use |
PCT/DK1994/000092 WO1994020496A1 (en) | 1993-03-05 | 1994-03-04 | Heterocyclic compounds and their preparation and use |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960701049A true KR960701049A (ko) | 1996-02-24 |
KR100344329B1 KR100344329B1 (ko) | 2002-11-30 |
Family
ID=21834696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950703745A KR100344329B1 (ko) | 1993-03-05 | 1994-03-04 | 아자비사이클릭화합물,이의제조방법및이를함유하는약제학적조성물 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5418240A (ko) |
EP (1) | EP0687266B1 (ko) |
JP (1) | JP3411923B2 (ko) |
KR (1) | KR100344329B1 (ko) |
CN (1) | CN1046722C (ko) |
AT (1) | ATE173257T1 (ko) |
AU (1) | AU694415B2 (ko) |
CZ (1) | CZ290639B6 (ko) |
DE (1) | DE69414554T2 (ko) |
DK (1) | DK0687266T3 (ko) |
ES (1) | ES2126099T3 (ko) |
FI (1) | FI954130A (ko) |
HU (1) | HUT72443A (ko) |
IL (1) | IL108865A (ko) |
NO (1) | NO312676B1 (ko) |
NZ (1) | NZ262372A (ko) |
PH (1) | PH31394A (ko) |
SK (1) | SK281005B6 (ko) |
TW (1) | TW350846B (ko) |
WO (1) | WO1994020496A1 (ko) |
ZA (1) | ZA941542B (ko) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5641791A (en) * | 1991-08-13 | 1997-06-24 | Novo Nordisk A.S | Heterocyclic compounds and their preparation and use |
MX9300875A (es) | 1992-02-20 | 1993-08-31 | Smithkline Beecham Plc | Procedimiento para la preparacion de compuestos azabiciclicos. |
US6265419B1 (en) | 1993-12-21 | 2001-07-24 | Novo Nordisk A/S | Method of treating gastrointestinal motility disorders |
US5663182A (en) * | 1993-08-19 | 1997-09-02 | Bymaster; Franklin Porter | Antipsychotic method |
US6271229B1 (en) | 1993-08-19 | 2001-08-07 | Novo Nordisk A/S | Method of treating gastrointestinal motility disorders |
PT714394E (pt) * | 1993-08-19 | 2001-12-28 | Novo Nordisk As | Metodo antipsicotico com derivados de tiadiazol e oxadiazol |
GB9409705D0 (en) * | 1994-05-14 | 1994-07-06 | Smithkline Beecham Plc | Novel compounds |
US5605908A (en) * | 1994-10-24 | 1997-02-25 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5998404A (en) | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5821371A (en) * | 1994-10-24 | 1998-10-13 | Eli Lilly And Comany | Heterocyclic compounds and their preparation and use |
US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
US5726193A (en) * | 1994-10-31 | 1998-03-10 | Eli Lilly And Company | Method for treating anxiety |
US5612351A (en) * | 1994-11-08 | 1997-03-18 | Novo Nordisk A/S | Method of treating urinary bladder dysfunctions |
WO1997011073A1 (en) * | 1995-09-22 | 1997-03-27 | Novo Nordisk A/S | Novel substituted azacyclic or azabicyclic compounds |
JP3462505B2 (ja) * | 1995-10-13 | 2003-11-05 | ノイロサーチ アクティーゼルスカブ | 8−アザビシクロ[3.2.1]オクト−2−エン誘導体、それらの製造及び使用 |
US5998434A (en) * | 1995-12-06 | 1999-12-07 | Eli Lilly And Company | Composition for treating pain |
KR19990071976A (ko) * | 1995-12-07 | 1999-09-27 | 피터 지. 스트링거 | 통증 치료용 조성물 |
WO1997025043A1 (en) * | 1996-01-04 | 1997-07-17 | Novo Nordisk A/S | A method of treating hypercholesterolemia and related disorders |
US5914338A (en) * | 1996-04-02 | 1999-06-22 | Novo Nordisk | Heterocyclic compounds and their preparation and use |
EP0900204A4 (en) * | 1996-04-23 | 2001-03-21 | Lilly Co Eli | HETEROCYCLIC CONNECTIONS |
CA2252563A1 (en) * | 1996-04-24 | 1997-10-30 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
US5733912A (en) * | 1997-02-19 | 1998-03-31 | Abbott Laboratories | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission |
JP2001520653A (ja) * | 1997-04-11 | 2001-10-30 | エリ リリー アンド カンパニー | 精神分裂病の治療法 |
AU6966998A (en) * | 1997-04-11 | 1998-11-11 | Eli Lilly And Company | Composition for treating pain |
US6015813A (en) * | 1997-04-22 | 2000-01-18 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
ATE299504T1 (de) * | 1997-04-22 | 2005-07-15 | Novo Nordisk As | Heterozyklische verbindungen, ihre herstellung und ihre anwendung |
WO1998054179A1 (en) * | 1997-05-29 | 1998-12-03 | Eli Lilly And Company | Process for preparing heterocyclic compounds |
WO1998054151A1 (en) * | 1997-05-29 | 1998-12-03 | Eli Lilly And Company | Process for preparing heterocyclic compounds |
US6465467B1 (en) * | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
WO2002015906A1 (en) * | 2000-08-21 | 2002-02-28 | Georgetown University | 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
EP2296471A4 (en) | 2008-05-15 | 2012-03-14 | Univ Toledo | MUSCARIC ACID AGONISTS AS COGNITIVE ENHANCERS |
WO2012149524A1 (en) | 2011-04-29 | 2012-11-01 | The University Of Toledo | Muscarinic agonists as enhancers of working memory and cognitive flexibility |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
GB8610432D0 (en) * | 1986-04-29 | 1986-06-04 | Akzo Nv | Amino-thiazole & oxazole derivatives |
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
IL88156A (en) * | 1987-11-13 | 1997-02-18 | Novo Nordisk As | Azacyclic compounds their preparation and pharmaceutical compositions containing them |
EP0322182A3 (en) * | 1987-12-22 | 1992-01-02 | Beecham Group Plc | Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
DK162892C (da) * | 1988-07-04 | 1992-05-11 | Novo Nordisk As | 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse |
US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
EP0459568A3 (en) * | 1990-05-31 | 1992-09-30 | Merck Sharp & Dohme Ltd. | Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use |
DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
-
1993
- 1993-03-05 US US08/026,943 patent/US5418240A/en not_active Expired - Lifetime
-
1994
- 1994-02-28 TW TW083101718A patent/TW350846B/zh active
- 1994-03-04 CN CN94191810A patent/CN1046722C/zh not_active Expired - Fee Related
- 1994-03-04 WO PCT/DK1994/000092 patent/WO1994020496A1/en active IP Right Grant
- 1994-03-04 KR KR1019950703745A patent/KR100344329B1/ko not_active IP Right Cessation
- 1994-03-04 DK DK94908990T patent/DK0687266T3/da active
- 1994-03-04 NZ NZ262372A patent/NZ262372A/en unknown
- 1994-03-04 DE DE69414554T patent/DE69414554T2/de not_active Expired - Fee Related
- 1994-03-04 AT AT94908990T patent/ATE173257T1/de not_active IP Right Cessation
- 1994-03-04 HU HU9502588A patent/HUT72443A/hu unknown
- 1994-03-04 ES ES94908990T patent/ES2126099T3/es not_active Expired - Lifetime
- 1994-03-04 AU AU62027/94A patent/AU694415B2/en not_active Ceased
- 1994-03-04 JP JP51948094A patent/JP3411923B2/ja not_active Expired - Fee Related
- 1994-03-04 EP EP94908990A patent/EP0687266B1/en not_active Expired - Lifetime
- 1994-03-04 PH PH47880A patent/PH31394A/en unknown
- 1994-03-04 ZA ZA941542A patent/ZA941542B/xx unknown
- 1994-03-04 CZ CZ19952251A patent/CZ290639B6/cs not_active IP Right Cessation
- 1994-03-04 SK SK1101-95A patent/SK281005B6/sk unknown
- 1994-03-04 IL IL10886594A patent/IL108865A/xx active IP Right Grant
-
1995
- 1995-09-04 FI FI954130A patent/FI954130A/fi not_active Application Discontinuation
- 1995-09-05 NO NO19953491A patent/NO312676B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH08507499A (ja) | 1996-08-13 |
IL108865A (en) | 2000-07-16 |
WO1994020496A1 (en) | 1994-09-15 |
AU6202794A (en) | 1994-09-26 |
CZ290639B6 (cs) | 2002-09-11 |
DK0687266T3 (da) | 1999-07-26 |
CN1046722C (zh) | 1999-11-24 |
SK281005B6 (sk) | 2000-10-09 |
NO953491L (no) | 1995-09-05 |
ZA941542B (en) | 1995-09-04 |
IL108865A0 (en) | 1994-06-24 |
HU9502588D0 (en) | 1995-11-28 |
ES2126099T3 (es) | 1999-03-16 |
KR100344329B1 (ko) | 2002-11-30 |
NO312676B1 (no) | 2002-06-17 |
HUT72443A (en) | 1996-04-29 |
FI954130A0 (fi) | 1995-09-04 |
NO953491D0 (no) | 1995-09-05 |
PH31394A (en) | 1998-10-29 |
EP0687266B1 (en) | 1998-11-11 |
JP3411923B2 (ja) | 2003-06-03 |
DE69414554T2 (de) | 1999-06-17 |
CZ225195A3 (en) | 1996-04-17 |
NZ262372A (en) | 1997-07-27 |
SK110195A3 (en) | 1996-10-02 |
AU694415B2 (en) | 1998-07-23 |
TW350846B (en) | 1999-01-21 |
DE69414554D1 (de) | 1998-12-17 |
CN1121349A (zh) | 1996-04-24 |
US5418240A (en) | 1995-05-23 |
EP0687266A1 (en) | 1995-12-20 |
FI954130A (fi) | 1995-10-27 |
ATE173257T1 (de) | 1998-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960701049A (ko) | 헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use) | |
ZA916581B (en) | Heterocyclic compounds and their preparation and use | |
ZA916579B (en) | Heterocyclic compounds and their preparation and use | |
FI954131A (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
DK0544714T3 (da) | Heterocycliske forbindelser og fremstilling og anvendelse deraf | |
CA2157579A1 (en) | Heterocyclic compounds, their use and preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |